The Industrial Internet of Things (IIoT) is revolutionizing biomanufacturing, a crucial element of the broader movement toward Industry 4.0. By leveraging the power of interconnected devices and systems, bioprocessing facilities are experiencing a surge in productivity and operational efficiency.
The biopharmaceutical manufacturing landscape is undergoing a significant transformation, with the emergence of continuous bioprocessing as a key innovative approach. This article will explore the various facets of this paradigm shift and its impact on the industry. The Shift from Traditional Batch
Certainly! Here's the formatted content with headings: Artificial tissue engineering is at the thrilling intersection of robotics and biomedical science, promising to revolutionize healthcare. This field utilizes robotic precision and cellular knowledge to address health issues and organ
Researchers from Weill Cornell Medicine and Cornell Engineering have achieved a groundbreaking advancement in tissue engineering by creating a lifelike adult human ear using state-of-the-art 3D printing technology. Published in the journal Acta Biomaterialia, this innovative development could
Paris-based startup Alt Biotech has recently caught the eye of the biotech industry through an impressive victory in an innovation competition sponsored by INTEGRA. At the helm of this groundbreaking company is Dr. Jade Pellet, the co-founder and Chief Scientific Officer, who is spearheading the
Certainly! Here is the content formatted with the appropriate heading designations: The synthetic biology sector is on a trajectory to monumental expansion, expected to reach a valuation of $52.6 billion by 2030. This interdisciplinary field combines biology, engineering, computer science, and
